← All Calumet, INC /DE filings

Calumet, INC /DE Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE: Two Seas Capital Acquires 7.5% Stake in Calumet Inc.
Investment firm Two Seas Capital LP, along with its GP and chief investment officer Sina Toussi, has reported beneficial ownership of 7.5% of Calumet, Inc.'s common stock as of June 30, 2026.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE: Calumet Inc. Ownership Update Filed
Wasserstein entities and individuals update beneficial ownership of Calumet Inc. common stock, reporting a combined 4.6% stake.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE: Adams Asset Advisors Reduces Stake in Calumet, Inc.
Adams Asset Advisors, LLC filed an amendment to its Schedule 13G, reporting a reduction in its beneficial ownership of Calumet, Inc. common stock to 4.68%.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE: Vanguard Group Reports 0% Stake in Calumet Inc
The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in Calumet Inc following an internal realignment.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE: Two Seas Capital Discloses 7.8% Stake in Calumet, Inc.
Two Seas Capital LP, along with its affiliates, has reported a 7.8% beneficial ownership stake in Calumet, Inc., totaling 6,752,538 shares as of September 30, 2025.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE: Two Seas Capital Discloses 5.2% Stake in Calumet
Two Seas Capital LP, along with its general partner and chief investment officer, has disclosed a 5.2% beneficial ownership stake in Calumet, Inc. as of June 30, 2025.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE: Vanguard Group Discloses 5.38% Stake in Calumet Inc.
The Vanguard Group has filed a Schedule 13G, reporting a 5.38% beneficial ownership stake in Calumet Inc.'s Common Stock.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE 13G: BlackRock Discloses 5.4% Stake in Calumet, Inc.
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.4% of Calumet, Inc.'s common stock as of June 30, 2025.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE 13G: Wasserstein Entities and Principals Disclose Significant Passive Stake in Calumet, Inc.
A group of investment entities and individuals associated with Wasserstein Debt Opportunities have filed a Schedule 13G, revealing a collective passive beneficial ownership of up to 7.0% of Calumet, Inc.'s common stock.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE 13G/A: Wasserstein Entities Amend Calumet, Inc. Stake Disclosure, Correcting Rajay Bagaria's Reported Ownership
Wasserstein Debt Opportunities Management, LP and related entities have filed an Amendment No. 5 to their Schedule 13G for Calumet, Inc., primarily to correct the number of shares directly beneficially owned by Rajay Bagaria.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE 13G/A: Wasserstein Entities Adjust Calumet, Inc. Stake Disclosure, Removing Feeder Fund
Wasserstein Debt Opportunities Management and related entities have filed an amended Schedule 13G for Calumet, Inc., primarily to remove a feeder fund previously included for EDGAR system access.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE 13G/A: Wasserstein Debt Opportunities and Principals Disclose Significant Stakes in Calumet, Inc.
Several investment entities and their control persons, including Wasserstein Debt Opportunities Management, LP and Rajay Bagaria, have disclosed beneficial ownership exceeding 5% in Calumet, Inc.'s common stock as of December 31, 2024.
NASDAQ
CLMT
Calumet, INC /DE
SCHEDULE 13G/A: Adams Asset Advisors Discloses 6.1% Passive Stake in Calumet, Inc. Following Corporate Reorganization
Adams Asset Advisors, LLC has filed an amended Schedule 13G, revealing a 6.1% passive beneficial ownership stake in Calumet, Inc. as of December 31, 2024, following a corporate reorganization.